The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Day One Biopharmaceuticals Inc (NASDAQ: DAWN) closed at $16.60 in the last session, down -3.32% from day before closing price of $17.17. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 1.13 million shares were traded. DAWN stock price reached its highest trading level at $17.1 during the session, while it also had its lowest trading level at $16.48.
Ratios:
We take a closer look at DAWN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.72 and its Current Ratio is at 12.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on April 24, 2024, Reiterated its Buy rating but revised its target price to $33 from $30 previously.
On April 25, 2023, BofA Securities Downgraded its rating to Underperform which previously was Buy and also lowered its target price recommendation from $34 to $9.
On February 08, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $40.CapitalOne initiated its Overweight rating on February 08, 2023, with a $40 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 03 ’24 when Bender Jeremy sold 9,154 shares for $17.85 per share. The transaction valued at 163,417 led to the insider holds 642,602 shares of the business.
York Charles N II sold 8,078 shares of DAWN for $144,214 on May 03 ’24. The COO, CFO AND SECRETARY now owns 217,293 shares after completing the transaction at $17.85 per share. On May 02 ’24, another insider, York Charles N II, who serves as the COO, CFO AND SECRETARY of the company, sold 200 shares for $17.90 each. As a result, the insider received 3,579 and left with 225,371 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1500266624 and an Enterprise Value of 1084649600.
Stock Price History:
Over the past 52 weeks, DAWN has reached a high of $18.07, while it has fallen to a 52-week low of $9.67. The 50-Day Moving Average of the stock is 7.63%, while the 200-Day Moving Average is calculated to be 21.18%.
Shares Statistics:
According to the various share statistics, DAWN traded on average about 1.03M shares per day over the past 3-months and 2647400 shares per day over the past 10 days. A total of 87.23M shares are outstanding, with a floating share count of 59.28M. Insiders hold about 32.16% of the company’s shares, while institutions hold 75.88% stake in the company. Shares short for DAWN as of 1713139200 were 8941942 with a Short Ratio of 8.64, compared to 1710460800 on 9608728. Therefore, it implies a Short% of Shares Outstanding of 8941942 and a Short% of Float of 12.770000000000001.
